- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Resistant Cystoid Macular Edema in Argentina
Total 22 results
-
Especialistas en Retina Medica y Quirurgica Grupo...Centro de Retina Medica y Quirurgica S.C.CompletedDiabetic Macular EdemaArgentina, Mexico
-
BayerCompletedMacular DegenerationMexico, Argentina, Colombia, Costa Rica
-
Hoffmann-La RocheCompletedDiabetic Macular EdemaGermany, United States, United Kingdom, Argentina, Canada, Italy, Poland
-
Hoffmann-La RocheActive, not recruitingDiabetic Macular EdemaUnited Kingdom, Korea, Republic of, United States, Argentina, Poland, Puerto Rico, Israel, Spain, Canada
-
Hoffmann-La RocheRecruitingUveitic Macular EdemaIndia, United States, Japan, Australia, Singapore, Turkey, Argentina, Germany, Czechia, Spain, France, Switzerland
-
EyeBiotech Ltd.RecruitingDiabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (NVAMD)United States, Argentina, Puerto Rico, United Kingdom
-
Hoffmann-La RocheActive, not recruitingDiabetic Macular EdemaUnited States, United Kingdom, Korea, Republic of, Argentina, Poland, Puerto Rico, Czechia, Spain, Canada
-
Hoffmann-La RocheCompletedDiabetic Macular EdemaUnited States, Korea, Republic of, United Kingdom, Brazil, Japan, Canada, Argentina, Australia, Austria, Denmark, France, Germany, Hungary, Italy, Poland, Slovakia, Spain, Singapore, Czechia, Hong Kong, Israel, Portugal, Russian Federation and more
-
Hoffmann-La RocheCompletedDiabetic Macular EdemaUnited States, Korea, Republic of, United Kingdom, Brazil, China, Canada, Argentina, Australia, Denmark, France, Italy, Poland, Spain, Germany, Singapore, Czechia, Hong Kong, Portugal, Russian Federation, Taiwan, Hungary, Switzerland and more
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more
-
Hoffmann-La RocheChugai PharmaceuticalCompletedMacular Edema | Branch Retinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaUnited States, Austria, Japan, Australia, Spain, Canada, Israel, Netherlands, Italy, United Kingdom, Portugal, Colombia, Puerto Rico, Argentina
-
Hoffmann-La RocheChugai PharmaceuticalCompletedCentral Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein OcclusionUnited States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
-
Austral University, ArgentinaRecruitingCardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk FactorArgentina
-
AstraZenecaRecruitingResistant HypertensionUnited States, Hungary, Poland, Belgium, Czechia, Spain, Vietnam, Argentina, Taiwan, Thailand, Turkey, Germany, Philippines, Bulgaria, Greece, Australia, Saudi Arabia, United Kingdom, South Africa, Canada, Slovakia, Malaysia
-
AstraZenecaRecruitingResistant Hypertension | Uncontrolled HypertensionArgentina, China, Korea, Republic of, Vietnam, Japan, Philippines, Hong Kong, Turkey, India, Australia, Russian Federation
-
AstraZenecaRecruitingResistant Hypertension | Uncontrolled HypertensionCanada, United States, South Africa, Korea, Republic of, Australia, Poland, Belgium, Japan, Spain, Vietnam, Argentina, Bulgaria, Turkey, Germany, Malaysia, Taiwan, Thailand, Italy, France, Israel, India, Netherlands, Sweden, United Kingdom and more
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPolycystic Kidney, Autosomal DominantBelgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedPolycystic Kidney Disease, Autosomal DominantUnited States, Belgium, United Kingdom, Russian Federation, France, Australia, Netherlands, Italy, Japan, Denmark, Romania, Poland, Canada, Argentina, Germany
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedChronic Kidney Disease | Autosomal Dominant Polycystic Kidney DiseaseAustralia, Belgium, Italy, Spain, Sweden, United States, Canada, Netherlands, Czechia, Poland, Germany, Russian Federation, Hungary, Israel, Puerto Rico, Argentina, Denmark, South Africa, United Kingdom, Norway, France, Romania